Guide To Treating Lambert-Eaton Myasthenic Syndrome
Intravenous Immunoglobulin

Intravenous immunoglobulin helps modulate the immune system to where it temporarily stops attacking the nerve cells. Immunoglobulin therapy is a way in which the physician can help manipulate the defective immune system into deactivation of the mechanisms acting on the neuromuscular junctions. There are, however, limitations of intravenous immunoglobulin when it comes to autoimmune disorder treatment such as in Lambert-Eaton myasthenic syndrome. This type of therapy will remove the harmful antibodies the immune system is producing that interfere with nerve communications. However, it will not stop the immune system from its abnormal production of such antibodies. This is most likely the reason why intravenous immunoglobulin is considered a temporary solution. It is also a treatment often used in conjunction with other methods for optimal effectiveness.
Continue reading to reveal more Lambert-Eaton myasthenic syndrome treatments now.